NJ State Employees Deferred Compensation Plan - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 68 filers reported holding AMICUS THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$206,720
-3.2%
17,0000.0%0.03%0.0%
Q2 2023$213,520
+13.3%
17,0000.0%0.03%
+6.9%
Q1 2023$188,530
-9.2%
17,0000.0%0.03%
-14.7%
Q4 2022$207,570
+17.3%
17,0000.0%0.03%
+13.3%
Q3 2022$177,000
-3.3%
17,0000.0%0.03%0.0%
Q2 2022$183,000
+13.7%
17,0000.0%0.03%
+36.4%
Q1 2022$161,000
-17.9%
17,0000.0%0.02%
-12.0%
Q4 2021$196,000
+21.0%
17,0000.0%0.02%
+13.6%
Q3 2021$162,000
-1.2%
17,0000.0%0.02%0.0%
Q2 2021$164,000
-2.4%
17,0000.0%0.02%
-8.3%
Q1 2021$168,000
+124.0%
17,000
+13.3%
0.02%
+60.0%
Q4 2016$75,000
-32.4%
15,0000.0%0.02%
-34.8%
Q3 2016$111,000
+35.4%
15,0000.0%0.02%
+35.3%
Q2 2016$82,000
-36.4%
15,0000.0%0.02%
-37.0%
Q1 2016$129,000
-11.6%
15,0000.0%0.03%
-10.0%
Q4 2015$146,000
-30.5%
15,0000.0%0.03%
-33.3%
Q3 2015$210,000
-0.9%
15,0000.0%0.04%
+9.8%
Q2 2015$212,000
+30.1%
15,0000.0%0.04%
+32.3%
Q1 2015$163,000
+30.4%
15,0000.0%0.03%
+29.2%
Q4 2014$125,000
+40.4%
15,0000.0%0.02%
+33.3%
Q3 2014$89,000
+78.0%
15,0000.0%0.02%
+80.0%
Q2 2014$50,000
+61.3%
15,0000.0%0.01%
+66.7%
Q1 2014$31,00015,0000.01%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Redmile Group, LLC 22,792,634$284,452,0008.05%
Perceptive Advisors 21,509,486$268,438,0006.16%
SECTORAL ASSET MANAGEMENT INC 3,324,623$41,491,0004.96%
Palo Alto Investors LP 7,796,299$97,298,0004.73%
Avoro Capital Advisors LLC 10,000,000$124,800,0004.31%
SPHERA FUNDS MANAGEMENT LTD. 2,510,320$31,329,0004.29%
Novo Holdings A/S 2,317,870$28,927,0004.05%
Ghost Tree Capital, LLC 1,450,000$18,096,0003.75%
Copernicus Capital Management, LLC 325,000$4,056,0003.61%
Boxer Capital, LLC 2,325,000$29,016,0002.50%
View complete list of AMICUS THERAPEUTICS INC shareholders